Effect of Topical Trimebutine on Pain After Hemorrhoidectomy
NCT ID: NCT03036111
Last Updated: 2017-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
42 participants
INTERVENTIONAL
2017-02-01
2018-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Botulinum Toxin Injection After Hemorrhoidectomy in Pain Control.
NCT05891314
Topical vs Oral Metronidazole After Benign Anorectal Surgery
NCT05038605
Topical Analgesia Post-Haemorrhoidectomy
NCT04276298
Topical Application of GTN 0.4% in the Treatment of Anismus Following Stapled Haemorrhoidopexy
NCT01279551
Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative Study
NCT06307106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemorrhoidectomy
Patients will undergo Millgan-Morgan hemorrhoidectomy as classically described before
Hemorrhoidectomy
Patients will undergo classic Milliagn-Morgan hemorrhoidectomy
trimebutine
Patients will undergo Millgan-Morgan hemorrhoidectomy then triembutine suppository will be inserted in the anal canal intraoperatively and then every six hours for 24 hours.
Trimebutine
Trimebutine suppository will be inserted in the anal canal on completion of hemorrhoidectomy then at six and 12 hours postoperatively.
Hemorrhoidectomy
Patients will undergo classic Milliagn-Morgan hemorrhoidectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trimebutine
Trimebutine suppository will be inserted in the anal canal on completion of hemorrhoidectomy then at six and 12 hours postoperatively.
Hemorrhoidectomy
Patients will undergo classic Milliagn-Morgan hemorrhoidectomy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with associated anorectal pathology such as anal fissure, anal fistula, rectal prolapse, neoplasm, solitary rectal ulcer, and inflammatory bowel diseases.\\
* Patients with recurrent hemorrhoids after previous surgery.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sameh Emile
Lecturer of general surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sameh H Emile, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mansoura University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura university hospital
Al Mansurah, Dakahlia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
mansourau20172
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.